VivoSim Labs (VIVS) EBITDA Margin (QoQ) (2011 - 2026)
VivoSim Labs (VIVS) EBITDA Margin (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -736,028.00 |
| Mar 31, 2026 | 260,942.00 |
| Dec 31, 2025 | -116,621.00 |
| Sep 30, 2025 | -153,234.00 |
| Jun 30, 2025 | -169,406.00 |
| Mar 31, 2025 | 826,569.00 |
| Dec 31, 2024 | -575,667.00 |
| Sep 30, 2024 | -1,128.00 |
| Jun 30, 2024 | 199,381.00 |
| Mar 31, 2024 | 6.29 Mn |
| Jun 30, 2023 | -79,148.00 |
| Mar 31, 2023 | -223,773.00 |
| Dec 31, 2022 | 179,172.00 |
| Dec 31, 2019 | -120,134.00 |
| Sep 30, 2019 | 42,116.00 |
| Jun 30, 2019 | 7,704.00 |
| Mar 31, 2019 | -21,549.00 |
| Dec 31, 2018 | -20,052.00 |
| Sep 30, 2018 | 46,249.00 |
| Jun 30, 2018 | -41,347.00 |